3DBioNet IBIN – London, UK – 20 Jan 2020
Registration is now open for the Joint 3DBioNet IBIN Meeting taking place January 20th –...
read moreThe Electrospinning Company offers contract services to design, develop and manufacture nanofibrous biomaterials for medical devices. Based on the electrospinning platform technology, they use their expertise and experience to support clients in a range of different therapeutic indications, including the supply of the first electrospun biomaterial incorporated into an FDA-approved medical device. The Company is also developing proprietary materials for targeted out-licensing opportunities, aiming to capture more of the end-market value. They are a spin-out from the UK Science and Technology Facilities Council (STFC) and are located on the Harwell Innovation Campus near Oxford, UK.
Status current
Associated Fund
GB EIS Fund,
UK Innovation & Science Seed Fund
Sector Medical / Biotechnology
Website www.electrospinning.co.uk/
Registration is now open for the Joint 3DBioNet IBIN Meeting taking place January 20th –...
read moreThe post World Biomaterials Congress – Glasgow, UK, 19-24th May 2020 appeared first on...
read moreCEO Ann Kramer will be speaking at the fourth annual biomaterials discovery workshop at...
read moreMeet our colleague and Mimetix-expert Stephen Jones at the 13th Drug Discovery ELRIG event...
read moreThe European patent office issued patent EP2812424 on 28th August 2019. The patented invention...
read moreMeet us at this year’s International College of Maxillofacial Surgery in Tel Aviv as...
read moreThe Electrospinning Company is the first investment from Midven's new GB EIS fund, through which…
read moreUpdate your browser to view this website correctly.Update my browser now